|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Amyotrophic Lateral Sclerosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Motor Neuron Disease | |||||
| Sclerosis | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Neuromuscular Diseases | |||||
| Pathologic Processes | |||||
| Spinal Cord Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||
| Massachusetts General Hospital | |||||